Figure 1
Flow of subjects through the study. A5, amlodipine 5 mg; AE, adverse event; H12.5, hydrochlorothiazide 12.5 mg; L50, losartan 50 mg.
Figure 1 | Hypertension Research
Flow of subjects through the study. A5, amlodipine 5 mg; AE, adverse event; H12.5, hydrochlorothiazide 12.5 mg; L50, losartan 50 mg.
